567 related articles for article (PubMed ID: 25604264)
1. Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance.
Adorno-Cruz V; Kibria G; Liu X; Doherty M; Junk DJ; Guan D; Hubert C; Venere M; Mulkearns-Hubert E; Sinyuk M; Alvarado A; Caplan AI; Rich J; Gerson SL; Lathia J; Liu H
Cancer Res; 2015 Mar; 75(6):924-9. PubMed ID: 25604264
[TBL] [Abstract][Full Text] [Related]
2. New Advances and Challenges of Targeting Cancer Stem Cells.
Dashzeveg NK; Taftaf R; Ramos EK; Torre-Healy L; Chumakova A; Silver DJ; Alban TJ; Sinyuk M; Thiagarajan PS; Jarrar AM; Turaga SM; Saygin C; Mulkearns-Hubert E; Hitomi M; Rich JN; Gerson SL; Lathia JD; Liu H
Cancer Res; 2017 Oct; 77(19):5222-5227. PubMed ID: 28928129
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
4. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
5. The challenge of targeting cancer stem cells to halt metastasis.
Agliano A; Calvo A; Box C
Semin Cancer Biol; 2017 Jun; 44():25-42. PubMed ID: 28323021
[TBL] [Abstract][Full Text] [Related]
6. Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications.
Paul R; Dorsey JF; Fan Y
Pharmacol Ther; 2022 Mar; 231():107985. PubMed ID: 34480963
[TBL] [Abstract][Full Text] [Related]
7. The cancer stem-cell signaling network and resistance to therapy.
Carnero A; Garcia-Mayea Y; Mir C; Lorente J; Rubio IT; LLeonart ME
Cancer Treat Rev; 2016 Sep; 49():25-36. PubMed ID: 27434881
[TBL] [Abstract][Full Text] [Related]
8. The clinical and therapeutic implications of cancer stem cell biology.
Cheng L; Alexander R; Zhang S; Pan CX; MacLennan GT; Lopez-Beltran A; Montironi R
Expert Rev Anticancer Ther; 2011 Jul; 11(7):1131-43. PubMed ID: 21806335
[TBL] [Abstract][Full Text] [Related]
9. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
11. Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance.
Das PK; Pillai S; Rakib MA; Khanam JA; Gopalan V; Lam AKY; Islam F
Stem Cell Rev Rep; 2020 Apr; 16(2):397-412. PubMed ID: 31965409
[TBL] [Abstract][Full Text] [Related]
12. Targeting pancreatic cancer stem cells for cancer therapy.
Xia J; Chen C; Chen Z; Miele L; Sarkar FH; Wang Z
Biochim Biophys Acta; 2012 Dec; 1826(2):385-99. PubMed ID: 22728049
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
14. Road to stemness in hepatocellular carcinoma.
Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma stem cells - mechanisms of chemoresistance and histone deacetylase inhibitors.
Khalil MA; Hrabeta J; Cipro S; Stiborova M; Vicha A; Eckschlager T
Neoplasma; 2012; 59(6):737-46. PubMed ID: 22862175
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells: A brief review of the current status.
Kuşoğlu A; Biray Avcı Ç
Gene; 2019 Jan; 681():80-85. PubMed ID: 30268439
[TBL] [Abstract][Full Text] [Related]
17. Targeting Cancer Stem Cells in Oral Cancer.
Xu Q; Le AD
J Calif Dent Assoc; 2016 Feb; 44(2):112-20. PubMed ID: 26930754
[TBL] [Abstract][Full Text] [Related]
18. The epigenetic/noncoding origin of tumor dormancy.
Crea F; Nur Saidy NR; Collins CC; Wang Y
Trends Mol Med; 2015 Apr; 21(4):206-11. PubMed ID: 25771096
[TBL] [Abstract][Full Text] [Related]
19. Pathobiology of pancreatic cancer: implications on therapy.
Regel I; Hausmann S; Benitz S; Esposito I; Kleeff J
Expert Rev Anticancer Ther; 2016; 16(2):219-27. PubMed ID: 26652651
[TBL] [Abstract][Full Text] [Related]
20. Harnessing cancer stem cell-derived exosomes to improve cancer therapy.
Yang J; Teng Y
J Exp Clin Cancer Res; 2023 May; 42(1):131. PubMed ID: 37217932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
